Published in Circulation on January 26, 2009
Mortality associated with low serum sodium concentration in maintenance hemodialysis. Am J Med (2011) 2.85
Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapy. Am J Kidney Dis (2014) 2.70
The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis. Mayo Clin Proc (2010) 2.55
Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis (2010) 2.47
Association of hemodialysis treatment time and dose with mortality and the role of race and sex. Am J Kidney Dis (2009) 2.25
Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients. Am J Transplant (2011) 2.10
Hypervolemia is associated with increased mortality among hemodialysis patients. Hypertension (2010) 1.98
Dialysate sodium and sodium gradient in maintenance hemodialysis: a neglected sodium restriction approach? Nephrol Dial Transplant (2011) 1.92
Shorter dialysis times are associated with higher mortality among incident hemodialysis patients. Kidney Int (2010) 1.83
Impact of race on hyperparathyroidism, mineral disarrays, administered vitamin D mimetic, and survival in hemodialysis patients. J Bone Miner Res (2010) 1.79
Dialysate sodium concentration and the association with interdialytic weight gain, hospitalization, and mortality. Clin J Am Soc Nephrol (2011) 1.74
Role of nutritional status and inflammation in higher survival of African American and Hispanic hemodialysis patients. Am J Kidney Dis (2011) 1.74
Disentangling the ultrafiltration rate-mortality association: the respective roles of session length and weight gain. Clin J Am Soc Nephrol (2013) 1.67
Interdialytic weight gain, systolic blood pressure, serum albumin, and C-reactive protein levels change in chronic dialysis patients prior to death. Kidney Int (2013) 1.56
Association of cumulatively low or high serum calcium levels with mortality in long-term hemodialysis patients. Am J Nephrol (2010) 1.52
Comparing body composition assessment tests in long-term hemodialysis patients. Am J Kidney Dis (2010) 1.36
Serum amyloid A in uremic HDL promotes inflammation. J Am Soc Nephrol (2012) 1.27
Intradialytic hypotension and risk of cardiovascular disease. Clin J Am Soc Nephrol (2014) 1.15
Bioimpedance-guided fluid management in hemodialysis patients. Clin J Am Soc Nephrol (2013) 1.10
Pulmonary congestion predicts cardiac events and mortality in ESRD. J Am Soc Nephrol (2013) 1.09
Serum creatinine level, a surrogate of muscle mass, predicts mortality in peritoneal dialysis patients. Nephrol Dial Transplant (2013) 1.07
Hospital treatment for fluid overload in the Medicare hemodialysis population. Clin J Am Soc Nephrol (2010) 1.04
Association between fluid balance and survival in critically ill patients. J Intern Med (2014) 1.03
Incremental Hemodialysis, Residual Kidney Function, and Mortality Risk in Incident Dialysis Patients: A Cohort Study. Am J Kidney Dis (2016) 0.96
The mortality and hospitalization rates associated with the long interdialytic gap in thrice-weekly hemodialysis patients. Kidney Int (2015) 0.94
Effect of lowering dialysate sodium concentration on interdialytic weight gain and blood pressure in patients undergoing thrice-weekly in-center nocturnal hemodialysis: a quality improvement study. Am J Kidney Dis (2011) 0.92
Mortality of combined serum phosphorus and parathyroid hormone concentrations and their changes over time in hemodialysis patients. Bone (2014) 0.92
Patient-stated preferences regarding volume-related risk mitigation strategies for hemodialysis. Clin J Am Soc Nephrol (2014) 0.91
Sensitive troponins--which suits better for hemodialysis patients? Associated factors and prediction of mortality. PLoS One (2012) 0.90
Dietary restrictions in dialysis patients: is there anything left to eat? Semin Dial (2015) 0.89
Combining near-subject absolute and relative measures of longitudinal hydration in hemodialysis. Clin J Am Soc Nephrol (2009) 0.87
Pulmonary congestion and physical functioning in peritoneal dialysis patients. Perit Dial Int (2012) 0.86
The impact of kidney transplantation on heart failure risk varies with candidate body mass index. Am Heart J (2009) 0.86
Nephrologist caseload and hemodialysis patient survival in an urban cohort. J Am Soc Nephrol (2013) 0.85
Dietary egg whites for phosphorus control in maintenance haemodialysis patients: a pilot study. J Ren Care (2011) 0.85
Patient perspectives on fluid management in chronic hemodialysis. J Ren Nutr (2009) 0.85
A retrospective, longitudinal study estimating the association between interdialytic weight gain and cardiovascular events and death in hemodialysis patients. BMC Nephrol (2015) 0.85
Increased incidence of diuretic use in critically ill obese patients. J Crit Care (2015) 0.85
Effect of Tenapanor on Interdialytic Weight Gain in Patients on Hemodialysis. Clin J Am Soc Nephrol (2016) 0.84
Blood volume-monitored regulation of ultrafiltration in fluid-overloaded hemodialysis patients: study protocol for a randomized controlled trial. Trials (2012) 0.83
Effective and timely evaluation of pulmonary congestion: qualitative comparison between lung ultrasound and thoracic bioelectrical impedance in maintenance hemodialysis patients. Medicine (Baltimore) (2015) 0.83
Aldosterone and mortality in hemodialysis patients: role of volume overload. PLoS One (2013) 0.83
Attending rounds: A patient with intradialytic hypotension. Clin J Am Soc Nephrol (2014) 0.83
Increased risk of volume overload with plasma compared with four-factor prothrombin complex concentrate for urgent vitamin K antagonist reversal. Transfusion (2015) 0.81
A phase 1 study of the safety, tolerability, pharmacodynamics, and pharmacokinetics of tenapanor in healthy Japanese volunteers. Clin Exp Nephrol (2016) 0.81
Fluid overload in hemodialysis patients: a cross-sectional study to determine its association with cardiac biomarkers and nutritional status. BMC Nephrol (2013) 0.81
High-volume postdilution hemodiafiltration is a feasible option in routine clinical practice. Artif Organs (2014) 0.80
Extreme Elevations in Blood Pressure and All-Cause Mortality in a Referred CKD Population: Results from the CRISIS Study. Int J Hypertens (2013) 0.80
Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients. Kidney Int Suppl (2011) (2013) 0.79
Daily ultrafiltration results in improved blood pressure control and more efficient removal of small molecules during hemodialysis. Blood Purif (2013) 0.79
Intradialytic Blood Pressure Abnormalities: The Highs, The Lows and All That Lies Between. Am J Nephrol (2015) 0.79
Dietary patterns and clinical outcomes in hemodialysis patients in Japan: a cohort study. PLoS One (2015) 0.78
Volume overload and adverse outcomes in chronic kidney disease: clinical observational and animal studies. J Am Heart Assoc (2015) 0.78
Pulmonary congestion in hemodialysis: an old chestnut worth screening for? Clin J Am Soc Nephrol (2013) 0.78
Diastolic heart failure: a confusing concept. Heart Fail Rev (2013) 0.77
Dose of hemodialysis and survival: a marginal structural model analysis. Am J Nephrol (2014) 0.77
Frequency of cardiovascular risk factors and metabolic syndrome in patients with chronic kidney disease. Clin Med Res (2010) 0.77
Left atrial dilatation and ST-T changes predict cardiovascular outcome in chronic hemodialysis patients. Heart Vessels (2011) 0.77
Low serum sodium is associated with protein energy wasting and increased interdialytic weight gain in haemodialysis patients. Clin Kidney J (2014) 0.77
Rapid ultrafiltration rates and outcomes among hemodialysis patients: re-examining the evidence base. Curr Opin Nephrol Hypertens (2015) 0.76
Effect of isovolemic, isothermic hemodialysis on cerebral perfusion and vascular stiffness using contrast computed tomography and pulse wave velocity. PLoS One (2013) 0.76
Pre-dialysis serum sodium and mortality in a national incident hemodialysis cohort. Nephrol Dial Transplant (2015) 0.76
Individualized reduction in dialysate sodium in conventional in-center hemodialysis. Hemodial Int (2012) 0.76
Indication for Dialysis Initiation and Mortality in Patients With Chronic Kidney Failure: A Retrospective Cohort Study. Am J Kidney Dis (2016) 0.76
Preclinical and Healthy Volunteer Studies of Potential Drug-Drug Interactions Between Tenapanor and Phosphate Binders. Clin Pharmacol Drug Dev (2016) 0.76
Bioimpedance spectroscopy method to determine hypervolemia in maintenance hemodialysis patients. Hippokratia (2016) 0.75
Camera on Vessel: A Camera-Based System to Measure Change in Water Volume in a Drinking Glass. Sensors (Basel) (2015) 0.75
A finger photoplethysmography waveform during the valsalva maneuver detects changes in left heart filling pressure after hemodialysis. BMC Nephrol (2015) 0.75
Seasonal variations in mortality and clinical indicators in international hemodialysis populations from the MONDO registry. BMC Nephrol (2015) 0.75
Posthemodialysis weights and mortality: another narrow range target? Clin J Am Soc Nephrol (2015) 0.75
Diagnostic accuracy of the defining characteristics of the excessive fluid volume diagnosis in hemodialysis patients. Rev Lat Am Enfermagem (2015) 0.75
Pattern and correlates of cardiac lesions in a group of sub-Saharan African patients on maintenance hemodialysis. Pan Afr Med J (2014) 0.75
Fluid volume expansion and depletion in hemodialysis patients lack association with clinical parameters. Can J Kidney Health Dis (2015) 0.75
Rationale and design of BISTRO: a randomized controlled trial to determine whether bioimpedance spectroscopy-guided fluid management maintains residual kidney function in incident haemodialysis patients. BMC Nephrol (2017) 0.75
Cardiovascular impact in patients undergoing maintenance hemodialysis: Clinical management considerations. Int J Cardiol (2017) 0.75
Influence of megestrol acetate on nutrition, inflammation and quality of life in dialysis patients. Int Urol Nephrol (2011) 0.75
Volume control by using the body composition monitor in a puerperal patient on hemodialysis. Electrolyte Blood Press (2011) 0.75
Lower serum potassium combined with lower sodium concentrations predict long-term mortality risk in hemodialysis patients. BMC Nephrol (2013) 0.75
The Use of a Multidimensional Measure of Dialysis Adequacy-Moving beyond Small Solute Kinetics. Clin J Am Soc Nephrol (2017) 0.75
Fluid management: the challenge of defining standards of care. Clin J Am Soc Nephrol (2014) 0.75
The Obesity Paradox in Kidney Disease: How to Reconcile it with Obesity Management. KI Rep (2017) 0.75
What are the causes of the ill effects of chronic hemodialysis? The fallacy of low interdialytic weight gain and low ultrafiltration rate: lower is not always better. Semin Dial (2013) 0.75
Identification of volume overload hospitalizations among hemodialysis patients using administrative claims: a validation study. BMC Nephrol (2016) 0.75
Cardiovascular complications in chronic dialysis patients. Curr Opin Nephrol Hypertens (2016) 0.75
The effect of low-sodium dialysate on ambulatory blood pressure measurement parameters in patients undergoing hemodialysis. Ther Clin Risk Manag (2015) 0.75
The Dialysis Sodium Gradient: A Modifiable Risk Factor for Fluid Overload. Nephron Extra (2017) 0.75
Use of lung ultrasonography to determine the accuracy of clinically estimated dry weight in chronic hemodialysis patients. Int Urol Nephrol (2017) 0.75
Blood Pressure and Risk of Cardiovascular Events in Patients on Chronic Hemodialysis: The CRIC Study (Chronic Renal Insufficiency Cohort). Hypertension (2017) 0.75
Turning the Tide: Improving Fluid Management in Dialysis through Technology. J Am Soc Nephrol (2017) 0.75
The impact of hemodialysis schedules on the day of the week of hospitalization for cardiovascular and infectious diseases, over a period of 20 years. PLoS One (2017) 0.75
Heart failure. N Engl J Med (2003) 9.75
A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int (2007) 4.68
An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J (2007) 3.62
Hormones and hemodynamics in heart failure. N Engl J Med (1999) 3.50
Validation of comorbid conditions on the end-stage renal disease medical evidence report: the CHOICE study. Choices for Healthy Outcomes in Caring for ESRD. J Am Soc Nephrol (2000) 3.27
Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol (2004) 3.08
The pathophysiology of acute heart failure--is it all about fluid accumulation? Am Heart J (2008) 2.84
Aldosterone in congestive heart failure. N Engl J Med (2001) 2.46
Excerpts from the United States Renal Data System 2006 Annual Data Report. Am J Kidney Dis (2007) 2.16
Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant (2005) 2.16
Racial and survival paradoxes in chronic kidney disease. Nat Clin Pract Nephrol (2007) 2.06
Association between serum ferritin and measures of inflammation, nutrition and iron in haemodialysis patients. Nephrol Dial Transplant (2004) 1.91
Detection limit of methods to assess fluid status changes in dialysis patients. Kidney Int (2006) 1.90
Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metab Care (2007) 1.82
Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th annual fall conference and scientific sessions. Hypertension (2005) 1.80
Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients. Am J Kidney Dis (2003) 1.77
Association between serum lipids and survival in hemodialysis patients and impact of race. J Am Soc Nephrol (2006) 1.76
A1C and survival in maintenance hemodialysis patients. Diabetes Care (2007) 1.75
Longitudinal associations between dietary protein intake and survival in hemodialysis patients. Am J Kidney Dis (2006) 1.58
Intrathoracic impedance to monitor heart failure status: a comparison of two methods in a chronic heart failure dog model. Congest Heart Fail (2005) 1.55
Albumin levels predict survival in patients with systolic heart failure. Am Heart J (2008) 1.48
Whole-body impedance--what does it measure? Am J Clin Nutr (1996) 1.36
Clinical assessment of dry weight. Nephrol Dial Transplant (1996) 1.34
Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. J Am Coll Cardiol (2007) 1.18
Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure. Cardiovasc Res (2006) 1.17
Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol (1990) 1.16
A cognitive behavioral group approach to enhance adherence to hemodialysis fluid restrictions: a randomized controlled trial. Am J Kidney Dis (2005) 1.15
Epidemiology of dialysis patients and heart failure patients. Semin Nephrol (2006) 1.13
Contemporary trends in the pharmacological and extracorporeal management of heart failure: a nephrologic perspective. Circulation (2008) 1.06
Assessment of dry weight by monitoring changes in blood volume during hemodialysis using Crit-Line. Kidney Int (2005) 1.05
Reverse epidemiology beyond dialysis patients: chronic heart failure, geriatrics, rheumatoid arthritis, COPD, and AIDS. Semin Dial (2007) 1.05
Nutritional and anti-inflammatory interventions in chronic heart failure. Am J Cardiol (2008) 1.01
Inflammatory pathways in patients with heart failure and preserved ejection fraction. Int J Cardiol (2007) 0.98
Long-term survival of incident hemodialysis patients who are hospitalized for congestive heart failure, pulmonary edema, or fluid overload. Clin J Am Soc Nephrol (2007) 0.97
Tipping the scale: heart failure, body mass index, and prognosis. Circulation (2007) 0.91
Monitoring of blood volume during haemodialysis treatment of acute renal and multiple organ failures. Nephrol Dial Transplant (1996) 0.90
Catecholamine effects on cardiac remodelling, oxidative stress and fibrosis in experimental heart failure. Redox Rep (2002) 0.87
Management of diuretic-refractory, volume-overloaded patients with acutely decompensated heart failure. Curr Cardiol Rep (2005) 0.84
Fluid management in patients on hemodialysis. Nephrol Nurs J (2007) 0.84
Are diuretics overused in the treatment of chronic heart failure? Nat Clin Pract Cardiovasc Med (2008) 0.82
Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation (2010) 13.28
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 11.88
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation (2013) 10.07
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation (2006) 8.01
Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA (2010) 6.91
Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA (2013) 5.05
Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate. N Engl J Med (2015) 5.03
Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail (2013) 4.98
Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA (2007) 4.89
Epidemiology and risk profile of heart failure. Nat Rev Cardiol (2010) 4.88
Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA (2006) 4.30
Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol (2005) 4.26
Get With the Guidelines-Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack. Circulation (2008) 4.00
US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis (2015) 3.94
2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation (2013) 3.86
Survival advantages of obesity in dialysis patients. Am J Clin Nutr (2005) 3.75
Linking inpatient clinical registry data to Medicare claims data using indirect identifiers. Am Heart J (2009) 3.57
Digoxin reduces 30-day all-cause hospital admission in older patients with chronic systolic heart failure. Am J Med (2013) 3.46
Expanding the evidence base in transplantation: the complementary roles of randomized controlled trials and outcomes research. Transplantation (2008) 3.43
Cardiorenal interactions: insights from the ESCAPE trial. J Am Coll Cardiol (2008) 3.35
State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail (2008) 3.35
Body mass index and mortality in heart failure: a meta-analysis. Am Heart J (2008) 3.25
Rehospitalization for heart failure: problems and perspectives. J Am Coll Cardiol (2012) 3.24
Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol (2004) 3.08
Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator. JAMA (2012) 3.07
Use of aldosterone antagonists in heart failure. JAMA (2009) 3.00
Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol (2002) 2.97
Is hospital admission for heart failure really necessary?: the role of the emergency department and observation unit in preventing hospitalization and rehospitalization. J Am Coll Cardiol (2013) 2.89
Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. J Am Soc Nephrol (2006) 2.89
Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. J Am Coll Cardiol (2010) 2.86
Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J (2007) 2.80
High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database. J Card Fail (2007) 2.75
Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study. Ann Intern Med (2013) 2.74
Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis. Am J Kidney Dis (2008) 2.74
The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J Lipid Res (2004) 2.72
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol (2005) 2.71
Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol (2010) 2.68
Predictors of adherence to performance measures in patients with acute myocardial infarction. Am J Med (2012) 2.64
Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail (2010) 2.64
Relation of loop diuretic dose to mortality in advanced heart failure. Am J Cardiol (2006) 2.59
Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality. J Am Soc Nephrol (2011) 2.59
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. J Am Coll Cardiol (2006) 2.57
The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis. Mayo Clin Proc (2010) 2.55
Racial and ethnic differences in the treatment of acute myocardial infarction: findings from the Get With the Guidelines-Coronary Artery Disease program. Circulation (2010) 2.53
Time-dependent associations between iron and mortality in hemodialysis patients. J Am Soc Nephrol (2005) 2.49
An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. J Am Coll Cardiol (2013) 2.47
Cardiac troponin and outcome in acute heart failure. N Engl J Med (2008) 2.41
Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). J Am Coll Cardiol (2008) 2.39
Race/ethnicity, quality of care, and outcomes in ischemic stroke. Circulation (2010) 2.32
Association of hemodialysis treatment time and dose with mortality and the role of race and sex. Am J Kidney Dis (2009) 2.25
A comparative effectiveness research study of the change in blood pressure during hemodialysis treatment and survival. Kidney Int (2013) 2.23
Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr (2008) 2.22
Sex differences in medical care and early death after acute myocardial infarction. Circulation (2008) 2.17
Need for increased awareness and evidence-based therapies for patients hospitalized for heart failure. JAMA (2013) 2.17
Four-variable risk model in men and women with heart failure. Circ Heart Fail (2013) 2.14
Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry. J Am Coll Cardiol (2009) 2.14
Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations. Am J Cardiol (2005) 2.11
An unexpected inverse relationship between HbA1c levels and mortality in patients with diabetes and advanced systolic heart failure. Am Heart J (2006) 2.11
Visual assessment of brain magnetic resonance imaging detects injury to cognitive regulatory sites in patients with heart failure. J Card Fail (2013) 2.07
Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines. Am Heart J (2008) 2.06
Racial and survival paradoxes in chronic kidney disease. Nat Clin Pract Nephrol (2007) 2.06
Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. J Am Soc Nephrol (2008) 2.05
Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol (2007) 2.05
B-type natriuretic peptide level and postdischarge thrombotic events in older patients hospitalized with heart failure: insights from the Acute Decompensated Heart Failure National Registry. Am Heart J (2012) 2.04
Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes. Circulation (2012) 2.03
Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial. Eur Heart J (2013) 1.99
Discharge to a skilled nursing facility and subsequent clinical outcomes among older patients hospitalized for heart failure. Circ Heart Fail (2011) 1.99
Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. Arch Intern Med (2007) 1.98
Association of disorders in mineral metabolism with progression of chronic kidney disease. Clin J Am Soc Nephrol (2006) 1.95
An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. Hypertension (2013) 1.95
Clinical effectiveness of implantable cardioverter-defibrillators among medicare beneficiaries with heart failure. Circ Heart Fail (2009) 1.95
Changes in myocardial infarction guideline adherence as a function of patient risk: an end to paradoxical care? J Am Coll Cardiol (2011) 1.92
Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals. Kidney Int Suppl (2010) 1.91
Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation (2003) 1.90
Associations of pretransplant weight and muscle mass with mortality in renal transplant recipients. Clin J Am Soc Nephrol (2011) 1.90
Waist circumference, body mass index, and survival in systolic heart failure: the obesity paradox revisited. J Card Fail (2011) 1.90
The obesity paradox in the elderly: potential mechanisms and clinical implications. Clin Geriatr Med (2009) 1.89
Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HF (Get With The Guidelines-Heart Failure) registry. J Am Coll Cardiol (2009) 1.88
A call to ACTION (acute coronary treatment and intervention outcomes network): a national effort to promote timely clinical feedback and support continuous quality improvement for acute myocardial infarction. Circ Cardiovasc Qual Outcomes (2009) 1.86
Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metab Care (2007) 1.82
Use of cardiac resynchronization therapy in patients hospitalized with heart failure. Circulation (2008) 1.81
Age and the associations of living donor and expanded criteria donor kidneys with kidney transplant outcomes. Am J Kidney Dis (2012) 1.81